DCCAX | FSSNX | DCCAX / FSSNX | |
Total Expense Ratio | 1.06 | 0.03 | 4,240% |
Annual Report Gross Expense Ratio | 1.06 | 0.03 | 4,240% |
Fund Existence | 27 years | 14 years | - |
Gain YTD | -2.883 | 0.650 | -443% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.57B | 25.9B | 25% |
Annual Yield % from dividends | 0.42 | 0.90 | 47% |
Returns for 1 year | 4.52 | 9.47 | 48% |
Returns for 3 years | 6.52 | 21.54 | 30% |
Returns for 5 years | 32.51 | 48.25 | 67% |
Returns for 10 years | 43.00 | 81.84 | 53% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
WTID | 14.88 | 0.35 | +2.39% |
MicroSectors™ Energy -3X Invrs Lvrgd ETN | |||
SCHF | 22.20 | 0.18 | +0.82% |
Schwab International Equity ETF™ | |||
FFC | 16.31 | 0.03 | +0.18% |
Flaherty & Crumrine Preferred and Income Securities Fund | |||
FPAG | 34.06 | -0.02 | -0.07% |
FPA Global Equity ETF | |||
BIB | 50.23 | -1.29 | -2.50% |
ProShares Ultra Nasdaq Biotechnology |